SPECTRUM PHARMACEUTICALS, INC.

(SPPI)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
0.8800 USD   -1.18%
06/23SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
06/10SPECTRUM PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
AQ
06/02Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Transcript : Spectrum Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022

05/12/2022 | 04:30pm EDT
Thank you for standing by, and welcome to Spectrum Pharmaceuticals First Quarter 2022 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded....


© S&P Capital IQ 2022
All news about SPECTRUM PHARMACEUTICALS, INC.
06/23SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers, Submission of Ma..
AQ
06/10SPECTRUM PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listi..
AQ
06/02Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences
BU
05/26Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predic..
BU
05/26ASCO 2022 : Circulating tumor DNA (ctDNA) in HER2 exon 20 insertion mutations and response..
PU
05/25SPECTRUM PHARMACEUTICALS : Current Corporate Presentation
PU
05/17SPECTRUM PHARMACEUTICALS INC Change in Directors or Principal Officers (form 8-K/A)
AQ
05/17SPECTRUM PHARMACEUTICALS INC : Change in Directors or Principal Officers, Financial Statem..
AQ
05/17Spectrum Pharmaceuticals to Participate in H.C. Wainwright Global Investment Conference
BU
05/12TRANSCRIPT : Spectrum Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022
CI
More news
Analyst Recommendations on SPECTRUM PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2022 7,30 M - -
Net income 2022 -90,9 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,74x
Yield 2022 -
Capitalization 155 M 155 M -
Capi. / Sales 2022 21,2x
Capi. / Sales 2023 1,38x
Nbr of Employees 164
Free-Float 90,2%
Chart SPECTRUM PHARMACEUTICALS, INC.
Duration : Period :
Spectrum Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SPECTRUM PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 0,88 $
Average target price 5,60 $
Spread / Average Target 536%
EPS Revisions
Managers and Directors
Thomas J. Riga President, CEO, CFO & Director
William L. Ashton Chairman
Francois Lebel Chief Medical Officer & Executive Vice President
Lyndah K. Dreiling Senior Vice President-Clinical Development
Dolatrai M. Vyas Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SPECTRUM PHARMACEUTICALS, INC.-30.71%155
MODERNA, INC.-43.20%57 385
IQVIA HOLDINGS INC.-24.22%40 468
LONZA GROUP AG-32.67%39 851
SEAGEN INC.16.00%33 010
CELLTRION, INC.-13.38%18 371